Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Clinical trial NCT06125041 · RECRUITING

Trial details

NCT number: NCT06125041
Sponsor: Qianfoshan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Small Cell Lung Cancer

Start date: 2023-10-30
Primary completion: 2026-07-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.